Patents by Inventor Angela Nocera

Angela Nocera has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INHIBITION OF CYSTATINS FOR THE TREATMENT OF CHRONIC RHINOSINUSITIS
    Publication number: 20230159659
    Abstract: Methods and compositions for the treatment of chronic rhinosinusitis in a subject, and more particularly to methods for treating chronic rhinosinusitis with nasal polyps in a subject with cystatin inhibitors.
    Type: Application
    Filed: July 29, 2019
    Publication date: May 25, 2023
    Inventors: Benjamin S. Bleier, Angela Nocera, Mansoor Amiji
  • Secreted P-glycoprotein is a Non-Invasive Biomarker of Chronic Rhinosinusitis
    Publication number: 20230111968
    Abstract: Methods for identifying and optionally treating subjects, e.g., subjects who have Chronic Rhinosinusitis (CRS), based on the detection of elevated levels of soluble P-glycoprotein in nasal secretions. The methods of treatment can include administration of a therapeutically effective amount of a P-glycoprotein inhibitor.
    Type: Application
    Filed: June 28, 2022
    Publication date: April 13, 2023
    Inventors: Benjamin S. Bleier, Angela Nocera
  • Secreted P-glycoprotein is a non-invasive biomarker of chronic rhinosinusitis
    Patent number: 11408900
    Abstract: Methods for identifying and optionally treating subjects, e.g., subjects who have Chronic Rhinosinusitis (CRS), based on the detection of elevated levels of soluble P-glycoprotein in nasal secretions. The methods of treatment can include administration of a therapeutically effective amount of a P-glycoprotein inhibitor.
    Type: Grant
    Filed: January 13, 2017
    Date of Patent: August 9, 2022
    Assignee: Massachusetts Eye and Ear Infirmary
    Inventors: Benjamin S. Bleier, Angela Nocera
  • Secreted P-glycoprotein is a Non-Invasive Biomarker of Chronic Rhinosinusitis
    Publication number: 20190086426
    Abstract: Methods for identifying and optionally treating subjects, e.g., subjects who have Chronic Rhinosinusitis (CRS), based on the detection of elevated levels of soluble P-glycoprotein in nasal secretions. The methods of treatment can include administration of a therapeutically effective amount of a P-glycoprotein inhibitor.
    Type: Application
    Filed: January 13, 2017
    Publication date: March 21, 2019
    Inventors: Benjamin S. Bleier, Angela Nocera